Skip to main content
Addgene

An O-Glycosylation of Fibronectin Mediates Hepatic Osteodystrophy Through alpha4beta1 Integrin.

Sens C, Altrock E, Rau K, Klemis V, von Au A, Pettera S, Uebel S, Damm T, Tiwari S, Moser M, Nakchbandi IA
J Bone Miner Res. 2017 Jan;32(1):70-81. doi: 10.1002/jbmr.2916. Epub 2016 Aug 3. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
120404Fibronectin-human-mutated N-terminal (N) O-Glycosylation siteenables eukaryotic expression of human plasma fibronectin in which the first O-glycosylation site was mutated from threonine to serine
120405Fibronectin-human-mutated V2 O-Glycosylation siteenables eukaryotic expression of human plasma fibronectin in which the second O-glycosylation site was mutated from threonine to serine
120406Fibronectin-human-mutated V1 O-Glycosylation siteenables eukaryotic expression of human plasma fibronectin in which the third O-glycosylation site was mutated from threonine to serine
120407Fibronectin-human-mutated N-terminal (N), V1 and V2 Glycosylation sitesenables eukaryotic expression of human plasma fibronectin in which all three O-glycosylation sites were mutated from threonine to serine

Antibodies from Article